Left ventricular diastolic dysfunction: risks, identification, and treatment

Area of Science:

• Cardiology
• Heart Failure Research

Background:

• Cardiovascular diseases (hypertension, diabetes, myocardial infarction) untreated increase chronic heart failure risk.
• Chronic heart failure with preserved systolic function (left ventricular diastolic dysfunction) lacks extensive clinical trial evidence compared to systolic dysfunction.
• Treatment for diastolic dysfunction has historically relied on understanding pathophysiology and patient symptoms.

Purpose of the Study:

• To review risks, identification, and therapeutic rationale for left ventricular diastolic dysfunction.
• To discuss emerging clinical evidence supporting treatments for diastolic dysfunction.
• To analyze implications from ongoing and completed trials like CHARM-Preserved and DIG.

Main Methods:

• Review of existing literature and clinical trial data.
• Analysis of risk factors and diagnostic approaches for diastolic dysfunction.
• Evaluation of therapeutic strategies and their supporting evidence.

Main Results:

• Accumulating clinical evidence from trials like CHARM-Preserved and DIG supports effective treatments for diastolic dysfunction.
• Ongoing trials are expected to provide further insights into managing this condition.
• Understanding pathophysiology and patient presentation remains crucial for treatment decisions.

Conclusions:

• Effective treatments for left ventricular diastolic dysfunction are becoming more defined.
• Clinical trial results are crucial for evidence-based management of diastolic dysfunction.
• Further research and ongoing trials will refine therapeutic choices for heart failure with preserved systolic function.